BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180710
DTEND;VALUE=DATE:20180713
DTSTAMP:20260515T051657
CREATED:20180511T110503Z
LAST-MODIFIED:20180511T110540Z
UID:15775-1531180800-1531439999@www.pharmajournalist.com
SUMMARY:IMPACCT: mHealth
DESCRIPTION:IMPACCT: mHealth 2018 is a unique dedicated forum where industry and clinical leaders can delve into clinical transformation in the making. \nProviding fresh insights into how leading pharmaceutical companies and clinical research organizations are actually transforming clinical trials with mobile and digital technology\, IMPACCT: mHealth looks beyond the theory or future promises\, to focus specifically on real-world examples and learnings that will help drive the implementation of mHealth and digital tools in clinical programs\, and overcome key operational\, regulatory and strategic challenges. \nAlong with over 90+ senior level experts from large pharma\, innovative biotech\, pioneering academia and expert solution providers\, this meeting will enable you to discover how they are accelerating clinical R&D\, promoting patient-centricity and advancing the use of patient-facing data. \nHow is mHealth and digital actually changing the way clinical trials are planned\, run and delivered today? \n What has changed\, and what will change around how mobile technology can disrupt the traditional clinical R&D model? \nThese are the questions to be explored and answered in this collaborative discussion. You’ll be able to hear the latest case-studies in this space\, and explore in full the applications and limitations of mobile and digital innovation in the context of clinical programs – with exclusive insights from organizations such as Pfizer\, Novartis\, CTTI\, Duke-Margolis Center for Health Policy\, Takeda\, AbbVie\, The Michael J. Fox Foundation\, UCB\, Eli Lilly or GSK. \nThese are exciting times for everyone actively involved in the efforts to bring the use of mHealth technologies in clinical research to the next level!
URL:https://www.pharmajournalist.com/event/impacct-mhealth/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="HansonWade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180711
DTEND;VALUE=DATE:20180713
DTSTAMP:20260515T051657
CREATED:20180502T080505Z
LAST-MODIFIED:20180503T163201Z
UID:15546-1531267200-1531439999@www.pharmajournalist.com
SUMMARY:6th Annual Clinical Operations in Oncology Trials East Coast 2018
DESCRIPTION:We are proud to present the Clinical Operations in Oncology Trials East Coast 2018. This is the only operationally focused oncology conference in the USA giving rise to invaluable discussions\, providing new insights into patient recruitment\, regulatory compliance and harnessing the power of data analytics to ensure successful\, timely and cost-effective oncology trials. \nWith Boston as a leading biotech hub for clinical trials and through partnering with MassBio we are going to expand our reach in the area to have senior representatives from all biotech’s to explore oncology trials whilst remaining operationally focused. \nWith a dynamic 2018 programme written for the industry\, by the industry\, this year promises to be truly engaging and informative.
URL:https://www.pharmajournalist.com/event/6th-annual-clinical-operations-in-oncology-trials-east-coast-2018/
LOCATION:Woburn\, MA
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
END:VCALENDAR